Brian L. has a diverse and extensive work experience in the financial planning and analysis field. Brian currently holds the position of Senior Director of Financial Planning and Analysis at Tessera Therapeutics. Prior to this, they served as the Director of Financial Planning and Analysis at the same company from September 2021 to March 2023.
Before joining Tessera Therapeutics, Brian worked at Takeda for over a decade, where they held various roles of increasing responsibility. Brian'smost recent position at Takeda was as Associate Director, Finance, Pharmaceutical Sciences (CMC) & Cell Therapies from August 2020 to September 2021. Brian also served as Senior Manager, Finance, Pharmaceutical Sciences (CMC) & Cell Therapies from March 2019 to July 2020, and Associate Manager-Manager, Finance, Pharmaceutical Sciences (CMC) from March 2016 to March 2019.
Prior to joining Takeda, Brian gained experience as a Financial Analyst and Associate Financial Analyst at various companies, including Fresenius Medical Care and Putnam Investments.
Overall, Brian's work experience demonstrates their expertise and proficiency in financial planning and analysis, with a focus on the pharmaceutical industry.
Brian L. obtained a Bachelor of Science degree in Business Administration with a focus on Finance and Economics from Northeastern University. Brian attended the university from 2007 to 2012.
January, 2023 - present
September, 2021